Ocular Therapeutix (OCUL) Reports Q4 Loss, Misses Revenue Estimates [Yahoo! Finance]
Ocular Therapeutix, Inc. (OCUL)
Last ocular therapeutix, inc. earnings: 3/12 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ocutx.com
Company Research
Source: Yahoo! Finance
These figures are adjusted for non-recurring items. A quarter ago, it was expected that this biotechnology company would post a loss of $0.27 per share when it actually produced a loss of $0.51, delivering a surprise of -88.89%. Over the last four quarters, the company has surpassed consensus EPS estimates just once. Ocular Therapeutix , which belongs to the Zacks Medical - Drugs industry, posted revenues of $14.8 million for the quarter ended December 2023, missing the Zacks Consensus Estimate by 3.29%. This compares to year-ago revenues of $14.08 million. The company has topped consensus revenue estimates just once over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Ocular Therapeutix shares have added about 123.8% since the beginning of the year versus the S&P 500's gain of 7.4%. What's Next for O
Show less
Read more
Impact Snapshot
Event Time:
OCUL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OCUL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OCUL alerts
High impacting Ocular Therapeutix, Inc. news events
Weekly update
A roundup of the hottest topics
OCUL
News
- Ocular Therapeutix™ To Present at Two Ophthalmology Meetings, May 4-9, 2024 [Yahoo! Finance]Yahoo! Finance
- Ocular Therapeutix™ To Present at Two Ophthalmology Meetings, May 4-9, 2024GlobeNewswire
- Ocular Therapeutix™ to Host Investor Day in New York City on Thursday, June 13, 2024 [Yahoo! Finance]Yahoo! Finance
- Ocular Therapeutix™ to Host Investor Day in New York City on Thursday, June 13, 2024GlobeNewswire
- Ocular Therapeutix, Inc. (NASDAQ: OCUL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.MarketBeat
OCUL
Earnings
- 3/11/24 - Miss
OCUL
Sec Filings
- 4/29/24 - Form ARS
- 4/29/24 - Form DEF
- 4/19/24 - Form PRE
- OCUL's page on the SEC website